Has David Essig, MD received payments from drug or device companies?

Yes. Drug and device makers reported $123,142 in general payments to David Essig, MD across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Essig, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Essig, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Essig, MD

Orthopedic Surgery · New York, NYNPI 1154588341

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $106,625 of the $123,142 with a category attached, or 86.6%. 10 manufacturers reported payments, led by Stryker at 51.1% of the total. 2025 is the largest year on record at $38,873, 9.2 times the $4,238 reported in 2019. Among orthopedic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$123,142in general payments, 2019–2025

Across 85 payments — averaging $1448.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$63K
VB Spine LLC$39K
Si-bone, Inc.$11K
Depuy Synthes Products, Inc.$4K
Medtronic$4K
Medical Device Business Services, Inc.$1K
plus $902 from 4 others

$59,535in research payments, 2019–2025

Across 10 payments — averaging $5953.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Prosidyan, Inc$49K
Depuy Synthes Products, Inc.$8K
Hoffmann-la Roche Limited$2K

What the payments were for

Consulting fees$106,62587%
Speaking & faculty fees$3,7803%
Travel & lodging$8,4467%
Food & beverage$4,2913%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	28	$62,973
VB Spine LLC	11	$38,519
Si-bone, Inc.	23	$10,955
Depuy Synthes Products, Inc.	8	$4,362
Medtronic(2 entities)	4	$4,083
Medical Device Business Services, Inc.	2	$1,348
Medicrea USA, Corp.	6	$563
Prosidyan, Inc	1	$179
Orthofix Medical, Inc.	1	$135
Johnson & Johnson	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$123,142 in reported general payments places this provider in the 90th percentile of 91 orthopedic surgery providers in New York.

See all orthopedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$368,640

Medicare patients

542

Services billed

1,712

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	55	$330
Cyclobenzaprine Hcl	27	$151
Tizanidine Hcl	14	$96
Meloxicam	17	$49
Gabapentin	11	$39

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in New York

Baron LonnerNew York$2.1M
Lon WeinerNew York$622K
James GladstoneNew York$260K
Thomas WickiewiczNew York$201K
Stephen ObrienNew York$17K
James SloverNew York$13K
Tyler LucasNew York$7K
Afshin RaziNew York$3K
Benjamin RosenstadtNew York$2K
Peter FrelinghuysenNew York$266

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →